EASO only develops projects that meet these objectives and that are designed to have an impact on patient, scientific and medical communities of Europe. These ambitious goals are achieved through collaboration with partners that share our strategic vision and promote a multi-stakeholder approach.
EASO only develops projects that meet these objectives and that are designed to have an impact on patient, scientific and medical communities of Europe. These ambitious goals are achieved through collaboration with partners that share our strategic vision and promote a multi-stakeholder approach. EASO only partners with organisations demonstrating a clear commitment to addressing the challenge of obesity in Europe and to helping EASO achieve its charitable objectives. EASO only accepts funding for specific projects and via unrestricted grants, and is currently engaged in project partnerships with Danone Research; Sanofi; Johnson and Johnson; and Novo Nordisk. All partnerships are governed by EASO Partnership Guidelines.